Europe/India/Near East USA Asia
Bachem AG Bachem Americas, Inc. Bachem Japan K.K.
Hauptstrasse 144 3132 Kashiwa Street AREA Shinagawa, 13F
4416 Bubendorf - Switzerland Torrance, CA 90505 - USA Tokyo 108-0075 - Japan
Tel +41 58 595 2021 Tel +1 888 422 2436 Tel +81 3 4405 3141
Fax +41 58 595 2040 Tel +1 888 4BACHEM Email sales.jp@bachem.com
Email sales.ch@bachem.com Fax +1 310 539 9428  
  E-mail sales.us@bachem.com  

BRADYKININ ACETATE 50 µg/VIAL (CLINALFA® BASIC)

Bradykinin Acetate 50 µg/vial (Clinalfa basic)

U-1080, 4056508

 
Sequence

H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH acetate salt

 
To be used in approved clinical trials only
 
Active Substance

The pharmacological effects of bradykinin include smooth muscle contraction, vasodilation and hypotension, increase in capillary permeability with oedema formation and induction of pain. Bradykinin induces bronchoconstriction in asthmatic subjects and symptoms of rhinitis on nasal provocation.

 
Literature References

A considerable number of publications on Clinalfa products used in clinical trials are available. The most important publications are listed here.
 

 
Note

This product is also available in research grade quality (non GMP)
 

H-1970

Bradykinin
(BK, Kallidin I, Kallidin-9, BRS-640)